Skip Navigation
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Your Environment. Your Health.

Publication Detail

Title: Glutamate-cysteine ligase attenuates TNF-induced mitochondrial injury and apoptosis.

Authors: Botta, Dianne; Franklin, Christopher C; White, Collin C; Krejsa, Cecile M; Dabrowski, Michael J; Pierce, Robert H; Fausto, Nelson; Kavanagh, Terrance J

Published In Free Radic Biol Med, (2004 Sep 1)

Abstract: Glutathione (GSH) is important in free radical scavenging, maintaining cellular redox status, and regulating cell survival in response to a wide variety of toxicants. The rate-limiting enzyme in GSH synthesis is glutamate-cysteine ligase (GCL), which is composed of catalytic (GCLC) and modifier (GCLM) subunits. To determine whether increased GSH biosynthetic capacity enhances cellular resistance to tumor necrosis factor-alpha- (TNF-alpha-) induced apoptotic cell death, we have established several mouse liver hepatoma (Hepa-1) cell lines overexpressing GCLC and/or GCLM. Cells overexpressing GCLC alone exhibit modest increases in GCL activity, while cells overexpressing both subunits have large increases in GCL activity. Importantly, cells overexpressing both GCL subunits exhibit increased resistance to TNF-induced apoptosis as judged by a loss of redox potential; mitochondrial membrane potential; translocation of cytochrome c to the cytoplasm; and activation of caspase-3, caspase-8, and caspase-9. Analysis of the effects of TNF on these parameters indicates that maintaining mitochondrial integrity mediates this protective effect in GCL-overexpressing cells.

PubMed ID: 15288121 Exiting the NIEHS site

MeSH Terms: Animals; Apoptosis/drug effects*; Carcinoma, Hepatocellular; Cell Line, Tumor; Glutamate-Cysteine Ligase/metabolism*; Glutathione/metabolism; Humans; Liver Neoplasms; Mice; Mitochondria/drug effects; Mitochondria/pathology*; Recombinant Proteins/metabolism; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.; Transfection; Tumor Necrosis Factor-alpha/toxicity*

to Top